89 related articles for article (PubMed ID: 8247779)
1. The synthesis of alternating alpha,beta-oligodeoxyribonucleotides with alternating (3'-->3')- and (5'-->5')-internucleotic linkages as potential therapeutic agents.
Koga M; Geyer SJ; Regan JB; Beaucage SL
Nucleic Acids Symp Ser; 1993; (29):3-4. PubMed ID: 8247779
[TBL] [Abstract][Full Text] [Related]
2. Biologically active oligodeoxyribonucleotides--I: Syntheses and anti-HIV-1 activities of 5'-modified pentadecadeoxyribonucleotides.
Hotoda H; Momota K; Furukawa H; Nakamura T; Kaneko M; Kimura S; Shimada K
Nucleic Acids Symp Ser; 1993; (29):59-61. PubMed ID: 8247795
[TBL] [Abstract][Full Text] [Related]
3. Molecular approaches to inhibit HIV-1 tat expression and functions.
Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
[No Abstract] [Full Text] [Related]
4. LNA and alpha-L-LNA: towards therapeutic applications.
Wengel J; Vester B; Lundberg LB; Douthwaite S; Sørensen MD; Babu BR; Gait MJ; Arzumanov A; Petersen M; Nielsen JT
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):601-4. PubMed ID: 14565236
[TBL] [Abstract][Full Text] [Related]
5. Evolution of a phosphorothioate RNA library during in vitro selection.
Kawakami J; Sugimoto N
Nucleic Acids Symp Ser; 1997; (37):201-2. PubMed ID: 9586069
[TBL] [Abstract][Full Text] [Related]
6. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
7. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
Dinauer N; Lochmann D; Demirhan I; Bouazzaoui A; Zimmer A; Chandra A; Kreuter J; von Briesen H
J Control Release; 2004 May; 96(3):497-507. PubMed ID: 15120905
[TBL] [Abstract][Full Text] [Related]
8. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
[TBL] [Abstract][Full Text] [Related]
9. Intravesical antisense therapy for cystitis using TAT-peptide nucleic acid conjugates.
Tyagi P; Banerjee R; Basu S; Yoshimura N; Chancellor M; Huang L
Mol Pharm; 2006; 3(4):398-406. PubMed ID: 16889433
[TBL] [Abstract][Full Text] [Related]
10. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
11. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
Naryshkin NA; Gait MJ; Ivanovskaya MG
Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
[TBL] [Abstract][Full Text] [Related]
12. Tat is required for efficient HIV-1 reverse transcription.
Harrich D; Ulich C; García-Martínez LF; Gaynor RB
EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
[TBL] [Abstract][Full Text] [Related]
13. [Sequence analysis of human immunodeficiency virus type 1 tat gene among the long-term HIV infected non-progressoris in Yunnan province].
Zhao F; Shao Y; Duan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):37-40. PubMed ID: 12759950
[TBL] [Abstract][Full Text] [Related]
14. Yeast SAS silencing genes and human genes associated with AML and HIV-1 Tat interactions are homologous with acetyltransferases.
Reifnyder C; Lowell J; Clarke A; Pillus L
Nat Genet; 1997 May; 16(1):109. PubMed ID: 9140406
[No Abstract] [Full Text] [Related]
15. Amino disaccharides having an alpha-(1-->4) or a beta-(1-->4) linkage, their synthesis and evaluation as a potential inhibitor for HIV-1 TAR-Tat.
Iguchi T; Ishikawa H; Matumoto H; Mizuno M; Goto K; Hamasaki K
Nucleic Acids Symp Ser (Oxf); 2005; (49):169-70. PubMed ID: 17150687
[TBL] [Abstract][Full Text] [Related]
16. The use of tat and env sequences from human immunodeficiency virus 1 in phylogenetic epidemiological studies.
Lorenzo E; Collins T; Fisher E; Herrera RJ
Electrophoresis; 2001 Feb; 22(3):438-44. PubMed ID: 11258752
[TBL] [Abstract][Full Text] [Related]
17. A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13.
Hoffmann S; Willbold D
Biochem Biophys Res Commun; 1997 Jun; 235(3):806-11. PubMed ID: 9207243
[TBL] [Abstract][Full Text] [Related]
18. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
19. GA/GC-rich sequence confers Tat responsiveness to human neurotropic virus promoter, JCVL, in cells derived from central nervous system.
Chowdhury M; Kundu M; Khalili K
Oncogene; 1993 Apr; 8(4):887-92. PubMed ID: 8384357
[TBL] [Abstract][Full Text] [Related]
20. A conditionally replicating virus as a novel approach toward an HIV vaccine.
Das AT; Verhoef K; Berkhout B
Methods Enzymol; 2004; 388():359-79. PubMed ID: 15289083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
